WHO: there may be 20 times more people infected with coronavirus than officially recognized - ForumDaily
The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

WHO: there may be 20 times more people infected with coronavirus than officially recognized

One in ten people in the world could become infected with coronavirus, which is 20 times more than the number of confirmed cases of infection. These assessments were shared by Dr. Michael Ryan, chairman of emergency situations of the World Health Organization, speaking at a meeting of the WHO board, writes "Voice of America".

Photo: Shutterstock

“The disease continues to spread. It grows in many countries around the world. We estimate that about 10% of the world's population may have become infected with the virus,” Ryan said.

The further spread of the disease indicates that the world "is entering a difficult period," the expert noted.

An estimated 760 million infections far exceed the number of confirmed cases of 35 million according to WHO and Johns Hopkins University, but that number means that most people in the world remain vulnerable to the virus.

A vaccine against COVID-19 may be ready by the end of 2020, the head of WHO said, writes Independent.

"The hope is that we may have a vaccine by the end of this year," Tedros Adhanom Ghebreyesus told a meeting of WHO leaders meeting to review the global response to the pandemic.

There are currently nine experimental vaccines under development from the Covax Global Vaccine Center, which plans to distribute two billion doses by the end of 2021.

At the moment, about 168 countries have joined the Covax program, but China, the United States and Russia are not among them.

Tedros urged countries to work together to fight the disease, saying that the most important factor in finding a vaccine is "the political commitment of our leaders, especially with regard to equitable distribution of vaccines."

He said: "We need each other, we need solidarity, and we need to use all the energy we have to fight the virus."

On the subject: The second wave of coronavirus: how to recognize it and which states have already encountered

Drug manufacturers and health authorities around the world are rushing to develop a vaccine that will be critical to contain the pandemic.

China is in talks with WHO to have its locally produced COVID-19 vaccines evaluated by the global health authority as a step towards making them available for international use, a WHO spokesman said.

In the meantime, the EU health regulator has begun a real-time review of a vaccine developed by US drug manufacturer Pfizer and German company BioNTech, which is expected to speed up the approval process by allowing researchers to submit results without waiting for studies to complete.

Both companies entered the final stages of negotiations with Europe last month to supply up to 300 million doses of their potential coronavirus vaccine.

There are currently 15 vaccine clinical trials underway in Africa. Five trials are taking place in South Africa, four in Egypt, and one each in Guinea-Bissau, Ghana, Uganda, Kenya, Zambia and Zimbabwe.

On the subject: Scientists have discovered a protein that neutralizes coronavirus without side effects

African countries have banded together to fight the pandemic, with painful memories of the millions of Africans who have died in the decade it took for HIV medicines to become available on the continent.

GlaxoSmithKline (GSK) and Vir Biotechnology also announced on Tuesday that the trial of their potential coronavirus vaccine will move into phase three.

The Comet-Ice study is evaluating Vir-7831 for early treatment of Covid-19 in patients at high risk of hospitalization.

The treatment is an antibody that has been selected based on its ability to neutralize the virus. It is also believed to kill infected cells, create a high barrier to resistance, and reach high concentrations in the lungs.

Following encouraging results from earlier stages of the study, the study will now be expanded globally to include additional centers in North America, South America and Europe.

Read also on ForumDaily:

'Not everyone knows why they came': how the Russian vaccine against COVID-19 is tested in humans

What are the October surprises and how they affect the outcome of the US elections

COVID-19, flu or cold: how to recognize the disease by the first symptoms

Israeli doctors have found a way to save patients with COVID-19 in critical condition

Fever and severe headache: COVID-19 vaccine test subjects report their well-being

Miscellanea vaccine WHO Educational program coronavirus Special Projects
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis. 



 
1071 requests in 1,122 seconds.